• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Veniti Inc.

Boston Scientific wins FDA approval for Vici peripheral venous stent

May 6, 2019 By Brad Perriello

Boston Scientific (NYSE:BSX) said today that it won pre-market approval from the FDA for the Vici peripheral venous stent it acquired when it bought Veniti last year. Marlborough, Mass.-based Boston Scientific said the FDA approved Vici for treating iliofemoral venous obstructive disease. The company inked a deal worth up to $160 million last August to acquire the […]

Filed Under: Featured, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Stents Tagged With: Boston Scientific, Peripheral, Veniti Inc.

Boston Scientific inks $160m deal for peripheral stent maker Veniti

August 8, 2018 By Fink Densford

Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $160 million to acquire stent developer Veniti. Marlborough, Mass.-based Boston Scientific said it currently owns 25% of the company and will pay $108 million in up-front cash for the remaining stake in Veniti, with an additional $52 million on the line in milestone payments […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Stents, Vascular Tagged With: Boston Scientific, Veniti Inc.

Veniti inks distro deal with Boston Scientific for Vici venous stent

September 11, 2017 By Fink Densford

Veniti said today it inked a limited global distribution deal with Boston Scientific (NYSE:BSX) for its Vici venous stent. The companies did not release details on which regions Boston Scientific would distribute the stent in or any financial terms of the deal. “The Vici venous stent is widely recognized as state-of-the-art technology for venous stents and physicians […]

Filed Under: Business/Financial News, Distribution, Stents, Vascular Tagged With: Veniti Inc.

Boston Scientific puts $25m into venous stent maker Veniti

September 8, 2016 By Brad Perriello

Veniti said today that Boston Scientific (NYSE:BSX) put up $25 million for its Series D round, which it plans to use to back a clinical trial of its Vici venous stent. Veniti’s 200-patient, 60-month Virtus trial, run under an investigational device exemption from the FDA, is a single-arm safety & efficacy study with a main safety endpoint of major adverse […]

Filed Under: Cardiovascular, Funding Roundup, Wall Street Beat Tagged With: Boston Scientific, Peripheral, Veniti Inc.

HNSN drums up $35m private placement | Medtech funding for the week of March 9, 2015

March 13, 2015 By MassDevice Leave a Comment

Robot-assisted surgery: Hansen Medical drums up $35m private placement

March 10, 2015 by Brad Perriello

Filed Under: Funding Roundup, News Well Tagged With: Aurora Spine, Biomet, Cardiac Dimensions Inc., Hansen Medical Inc., Veniti Inc., Zimmer Biomet

Podcast: Conquering venous disease with Veniti founder and chief Sean Morris

July 2, 2012 By Arezu Sarvestani

Veniti and CEO Sean Morris

Click to play

Veniti founder, president & CEO Sean Morris is on the march, looking to take over venous disease treatment with a suit of specialized devices that he hopes will knock out their more generic forebears.

Veniti, formed in 2009, specializes in devices for the venous anatomy, an arena often covered in a larger medical device company’s vascular devices business.

Filed Under: Device Talks Podcasts, News Well, Stents Tagged With: MassDevice Q&A, Veniti Inc.

SonoSite CFO resigns, makes $3M | Personnel Moves

January 6, 2012 By MassDevice staff Leave a Comment

SonoSite (NSDQ:SONO) CFO Marcus Smith stands to pull down more than $3 million now that he’s retired from the Bothell, Wash.-based ultrasound device maker.

The company said Smith’s resignation, which went into effect yesterday, was to pursue other opportunities.

The former Philips Medical Systems exec will end up with more than $3 million in the bank after he receives all of his separation benefits, according to a company filing with the SEC.

Filed Under: News Well Tagged With: Burrill & Co., Fujifilm, Globus Medical, Imaging3, InHealth, Lantheus Medical Imaging, NewCardio Inc., NovoCure, Personnel Moves, Rochester Medical Corp., Smith & Nephew, Veniti Inc.

Medtronic readies billion-dollar debt offering | Funding roundup

March 11, 2011 By MassDevice staff Leave a Comment

Funding Roundup

Medtronic Inc. (NYSE:MDT) is looking to drum up $1 billion through a debt offering.

The Fridley, Minn.-based medical device giant announced a registered offering of $500 million worth of its 2.625 percent senior notes, due 2016, and $500 million of its 4.125 percent senior notes due in 2021.

Filed Under: Business/Financial News, News Well Tagged With: BridgePoint Medical Inc., NovaShunt AG, Tornier Inc., Veniti Inc.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS